Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activating mutations and senescence secretome: new insights into HER2 activation, drug sensitivity and metastatic progression.

Breast cancer research : BCR - 23 Apr 2013

Acharyya Swarnali

Abstract excerpt

HER2 amplification and overexpression is observed in approximately 20% of breast cancers and is strongly associated with poor prognosis and therapeutic responsiveness to HER2 targeted agents. A recent study by Bose and colleagues suggests that another subset of breast cancer patients without HER2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cell Communication
Share to Cellular Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Drug Resistance, Neoplasm

Share to Mutation

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 23634980
DOI: 10.1186/bcr3406
PMCID: PMC3672670

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23634980-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activating mutations and senescence secretome: new insights into HER2 activation, drug sensitivity and metastatic progression.PMID 23634980Read ↗

p95HER2 and Breast CancerSemantic proximity Read ↗

Activating HER2 mutations as emerging targets in multiple solid cancersSemantic proximity Read ↗

A review of HER2 overexpression and somatic mutations in cancers.Semantic proximity Read ↗

HER2 mutation as an emerging target in advanced breast cancer.Semantic proximity Read ↗

HER2: Biology, Detection, and Clinical ImplicationsSemantic proximity Read ↗

Effect of Cellular Senescence on the Growth of HER2-Positive Breast CancersSemantic proximity Read ↗

A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and MetastasisSemantic proximity Read ↗

Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice VariantSemantic proximity Read ↗

Lipocalin 2 dictates cancer cell plasticity elicited by therapy-induced senescenceSemantic proximity Read ↗

HER2 expression identifies dynamic functional states within circulating breast cancer cells.Semantic proximity Read ↗

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionSemantic proximity Read ↗

The human epidermal growth factor receptor 2 (HER2)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.